Guardian Drug Company, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 2 Charles Court, Dayton, New Jersey (NJ) 08810, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 2245306 · DUNS 119210276
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-01-16
- NAIBioresearch Monitoring2024-11-07
- VAIDrug Quality Assurance2022-02-17
- VAIDrug Quality Assurance2017-11-06
- NAIDrug Quality Assurance2014-08-15
- VAIDrug Quality Assurance2012-06-08
- VAIDrug Quality Assurance2012-03-02
- VAIDrug Quality Assurance2011-02-18
- VAIDrug Quality Assurance2008-10-28
Drugs this plant is listed as making
6 distinct drugs across 12 products name this site in their FDA label.
- Diatrizoate Meglumine and Diatrizoate SodiumGuardian Drug Company
- Furosemidein shortageIpca Laboratories Limited
- Hydroxychloroquine SulfateIpca Laboratories Limited
- LevetiracetamGuardian Drug Company
- OndansetronGolden State Medical Supply, Inc.
- Potassium ChlorideGuardian Drug Company
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.